CASI Pharmaceuticals, Inc (CASI) Stock Price

0.9247 ▼ -0.0253 (-2.66%)
Open: 0.9237 Vol: 17.36K Day's range: 0.905 - 0.95 Feb 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CASI Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.91▲ 0.91▲ 0.91▲ 0.96▼ 0.99▼
MA10 0.91▲ 0.92▲ 0.92▼ 0.98▼ 0.92▲
MA20 0.94▼ 0.95▼ 0.96▼ 1.00▼ 1.20▼
MA50 0.96▼ 0.96▼ 0.96▼ 0.93▼ 1.61▼
MA100 0.95▼ 0.94▼ 0.98▼ 1.25▼ 2.99▼
MA200 1.03▼ 1.23▼ 1.33▼ 1.52▼ 3.13▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.005▼ -0.006▼ -0.007▼ 0.017▲
RSI 42.318▼ 44.828▼ 44.680▼ 44.062▼ 38.708▼
STOCH 56.913     31.602     18.537▼ 51.383     39.954    
WILL %R -64.387     -68.529     -71.692     -68.782     -76.068▼
CCI 2.379     -31.262     -41.003     -164.098▼ -40.597    
Latest Filters Detected On CASI
▼ MACD $CASI MACD(12,26,9) Crossed Below Zero Set Alert
MA $CASI Price Crossed Below MA(50) Set Alert
▼ GAP $CASI Open Gap Down %2 Set Alert
CDL $CASI Harami Candlestick Pattern Detected Set Alert
CDL $CASI Doji Candlestick Pattern Detected Set Alert
CASI Pharmaceuticals, Inc News
CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR)
Thursday, January 15, 2026 06:00 AM
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 15, 2026 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially ...
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
Tuesday, December 23, 2025 01:05 PM
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in ...
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
Thursday, December 11, 2025 06:00 AM
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 11, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI, the "Company"), a clinical-stage biopharmaceutical company developing CID-103, an ...
CASI historical stock data
date open high low close volume
06/02/26 0.9237 0.95 0.905 0.9247 17,364
05/02/26 0.91 1.03 0.8701 0.95 12,718
04/02/26 0.97 0.975 0.91 0.9425 10,946
03/02/26 1.0012 1.005 0.952 0.99 7,286
02/02/26 1.00 1.04 0.98 0.9864 22,962
30/01/26 0.99 1.03 0.99 1.02 52,007
29/01/26 0.97 1.02 0.97 0.9901 35,075
28/01/26 0.99 1.045 0.97 1.00 3,916
27/01/26 1.00 1.04 1.00 1.035 19,439
26/01/26 0.96 1.01 0.96 0.98 30,307
Quote Details
52wk Low:0.75
52wk High:3.09
Vol:17.36K
Avg Vol(3m):619K
1Y Chng:-62.26%
1M Chng:+18.25%
Add to Watch List
More Information
Index US Composite
Market Cap. 14.72M